Shareholders' Equity (Tables)

6 Months Ended

Jun. 30, 2024

Stockholders' Equity Note [Abstract]

Schedule of the impact of stock-based compensation expense

The Company recorded stock-based compensation expense as follows in the unaudited condensed consolidated statements of income and comprehensive income (in millions):

	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
Stock options	$	0.4	$	0.4	$	0.9	$	0.8
Restricted stock units		4.4		3.8		8.6		7.5
Employee Stock Purchase Plan		0.3		0.2		0.5		0.4
Total stock-based compensation expense	$	5.1	$	4.4	$	10.0	$	8.7

	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
Cost of product revenue	$	0.4	$	0.4	$	0.8	$	0.7
Selling, general and administrative		4.1		3.5		8.0		7.1
Research and development		0.6		0.5		1.2		0.9
Total stock-based compensation expense	$	5.1	$	4.4	$	10.0	$	8.7